Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000–2002: a retrospective analysis
Authors:
- Lorenzo CirasinoLCLorenzo Cirasino
- Anna M RobinoARAnna M Robino
- Marco CattaneoMCMarco Cattaneo
- Pietro E PioltelliPPPietro E Pioltelli
- Enrico M PoglianiEPEnrico M Pogliani
- Laura TerranovaLTLaura Terranova
- Enrica MorraEMEnrica Morra
- Paola ColomboPCPaola Colombo
- Giancarlo A PalmieriGPGiancarlo A Palmieri
- Prisco PiscitelliPPPrisco Piscitelli
- 1 January 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 21 (1) , 77-84
Abstract
The treatment of immune thrombocytopenic purpura (ITP) still offers challenges to clinicians and health professional organizations, despite recommendations provided by international guidelines. In order to improve the care of patients with ITP, it is useful to understand how often such patients receive appropriate treatment and if common errors occur that could be avoided. We retrospectively analyzed all the clinical records between 1 January, 2000 and 31 December, 2002 of patients receiving an ICD-9-CM diagnosis code of 287.3 in three hospitals in northern Italy. We examined whether management strategies of adult men and nonpregnant women with ITP were consistent or not with the guidelines provided by the American Society of Hematology. The ITP diagnosis was confirmed in 120 of 169 patients (71%). Reasons for admission were: medical treatment for ITP (51.7%), medical or surgical treatment of ITP-associated disorders (30.8%), elective splenectomy (15.8%) and diagnosis or observation of ITP (1.7%). Hospital admission resulted appropriate in 78.1% of cases. Therapeutic interventions were appropriate in 100% of cases for glucocorticoid treatment, 86.4% for splenectomy, 47.7% for high-dose immunoglobulins, 40.9% for prophylaxis against bleeding before splenectomy, 33.3% for high-dose glucocorticoid treatment, and 19% for prophylaxis against bacterial infections before splenectomy. Platelet transfusions as treatment for bleeding were appropriate in only 20% of cases. Confirming the usefulness of the American guidelines for ITP, our data suggest that there are important areas of inappropriate management of the disease, which could be corrected by adopting quality improvement programs and studies.Keywords
This publication has 25 references indexed in Scilit:
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literatureHaematologica, 2008
- Viral-Associated Immune Thrombocytopenic PurpuraHematology-American Society Hematology Education Program, 2008
- Rituximab therapy for chonic and refractory immune thrombocytopenic purpura: a long-term follow-up analysisAnnals of Hematology, 2007
- Secondary immune thrombocytopenic purpuraCurrent Opinion in Hematology, 2007
- Novel Thrombopoietic AgentsHematology-American Society Hematology Education Program, 2007
- ITP in the 21st CenturyHematology-American Society Hematology Education Program, 2006
- Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose DexamethasoneNew England Journal of Medicine, 2003
- Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancyBritish Journal of Haematology, 2003
- Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelinesThe Lancet, 1997